Wednesday, December 3, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Banking & Insurance

First of Long Island Acquisition Finalized: Key Investor Implications

Dieter Jaworski by Dieter Jaworski
September 1, 2025
in Banking & Insurance, Mergers & Acquisitions
0
First of Long Island Stock
0
SHARES
268
VIEWS
Share on FacebookShare on Twitter

The independent operations of The First of Long Island Corporation have officially concluded. As of June 2, 2025, ConnectOne Bancorp has successfully completed its acquisition of the institution. Investors who previously held FLIC stock now possess shares in ConnectOne Bancorp, as the original ticker has been retired.

Terms and Financial Structure of the Merger

Under the merger agreement, shareholders of The First of Long Island received 0.5175 shares of ConnectOne for each share of FLIC they owned. When this deal was initially announced to the market in September 2024, its total value was approximately $284 million. This translated to an implied value of roughly $12.40 per FLIC share at that time.

The combined entity now operates under the ConnectOne brand and boasts a significant asset base of about $14 billion. Its consolidated balance sheet includes $11 billion in deposits and an equivalent $11 billion in outstanding loans. The geographic footprint has been substantially expanded to include more than 60 branch locations across New York, New Jersey, and Southeastern Florida.

Leadership and Financial Projections Post-Merger

Key leadership changes have been implemented following the consolidation. Christopher Becker, the former President and Chief Executive Officer of First of Long Island, has transitioned to the role of Vice Chairman at ConnectOne. Furthermore, two independent directors from the FLIC board have been appointed to serve on ConnectOne’s board of directors.

Should investors sell immediately? Or is it worth buying First of Long Island?

Financially, the acquisition was projected to be accretive to ConnectOne’s earnings per share for the 2025 fiscal year, after accounting for all anticipated cost savings. However, the transaction did result in an estimated 12% dilution to tangible book value per share. The company expects this dilution to be earned back within a period of 2.9 years.

Implications for Former FLIC Shareholders

The first-quarter 2025 earnings report for First of Long Island, which was released on April 30, 2025, represents its final independent financial statement. The reported net income of $3.8 million, or $0.17 per share, has been incorporated into ConnectOne’s overall financial results.

All future financial performance, corporate actions, and dividend distributions will now be determined and executed solely by ConnectOne Bancorp. Market attention has now shifted entirely toward tracking the successful integration of the two banks and the realization of projected synergies from the merger.

Ad

First of Long Island Stock: Buy or Sell?! New First of Long Island Analysis from December 3 delivers the answer:

The latest First of Long Island figures speak for themselves: Urgent action needed for First of Long Island investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 3.

First of Long Island: Buy or sell? Read more here...

Tags: First of Long Island
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Bionxt Solutions Stock
Analysis

Bionxt Solutions Secures Key Licensing Deal in Cancer Therapy Market

December 3, 2025
European Lithium Stock
Commodities

Strategic Moves and Sector Momentum: European Lithium Navigates Shareholder Shifts and Capital Strategy

December 3, 2025
Netflix Stock
Analysis

Netflix Stock: Aggressive Expansion Strategy Takes Shape

December 3, 2025
Next Post
Tencent Holdings (ADR) Stock

Tencent's AI Investments Fuel Impressive Quarterly Performance

Visteon Stock

Visteon Shares Surge as Analysts Boost Price Targets Following Strong Quarter

Nautilus Biotechnology Stock

Is There Any Hope Left for Nautilus Biotechnology Investors?

Recommended

Capital One Stock

Major Institutions Back Capital One Despite Acquisition Costs

3 months ago
Coca-Cola Stock

Coca-Cola Stock: A Dual-Pronged Growth Strategy Takes Shape

1 week ago
Summit Therapeutics Stock

Summit Therapeutics: Clinical Data Divides Market as CEO Backs Conviction

3 months ago
SunHydrogen Stock

SunHydrogen Reaches Commercial Milestone with First Revenue

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Bionxt Solutions Secures Key Licensing Deal in Cancer Therapy Market

Strategic Moves and Sector Momentum: European Lithium Navigates Shareholder Shifts and Capital Strategy

Netflix Stock: Aggressive Expansion Strategy Takes Shape

Is Innovative Industrial Properties a Deep-Value Cannabis Play?

Is Alibaba’s Stock Dip a Strategic Entry Point?

Intellia Therapeutics Faces Critical Juncture Following Clinical Trial Death

Trending

Novo Nordisk Stock
Analysis

Novo Nordisk Faces Critical Juncture Amid Legal and Competitive Pressures

by Robert Sasse
December 3, 2025
0

The year 2025 is shaping up to be a formidable challenge for Novo Nordisk, with its share...

Ballard Power Stock

Is Ballard Power Stock Nearing an Inflection Point?

December 3, 2025
Redcare Pharmacy Stock

Redcare Pharmacy Shares Continue Their Steep Descent

December 3, 2025
Bionxt Solutions Stock

Bionxt Solutions Secures Key Licensing Deal in Cancer Therapy Market

December 3, 2025
European Lithium Stock

Strategic Moves and Sector Momentum: European Lithium Navigates Shareholder Shifts and Capital Strategy

December 3, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Faces Critical Juncture Amid Legal and Competitive Pressures
  • Is Ballard Power Stock Nearing an Inflection Point?
  • Redcare Pharmacy Shares Continue Their Steep Descent

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com